Viktória László

3.8k citations

70 papers · 2.3k indexed · h-index 29

Impact in

Oncology top 5%
- Lung Cancer Research Studies
Cancer Research top 5%

Papers in

Oncology 33
- Lung Cancer Research Studies 14
Pulmonary and Respiratory Medicine 30
- Occupational and environmental lung diseases 12
- Lung Cancer Treatments and Mutations 12
- Medical Imaging and Pathology Studies 7

Co-authors: Balázs Döme Balázs Hegedűs Walter Klepetko Mir Alireza Hoda Sándor Paku Anita Rózsás Katalin Dezső Péter Nagy
Journals: Scientific Reports (3 papers)Lung Cancer (3 papers)Translational Lung Cancer Research (3 papers)American Journal Of Pathology (3 papers)PLoS ONE (3 papers)
Partner nations: Hungary Austria United States

In The Last Decade

Viktória László

68 papers receiving 2.3k citations

Peers

Countries citing papers authored by Viktória László

Since Specialization

Citations

This map shows the geographic impact of Viktória László's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktória László with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktória László more than expected).

Fields of papers citing papers by Viktória László

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktória László. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktória László. The network helps show where Viktória László may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Viktória László, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Viktória László Line = papers co-authored together Viktória László links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer World Journal of Surgical Oncology ·Christian Lang, Zsolt Megyesfalvi, 昭義前原, Felicitas Oberndorfer, Mir Alireza Hoda, M. A., 严秀芳, János Fillinger, К. А. Черепанова, 谷一郎山賀, K.K. Unger, Kristiina Boettiger, Thomas Klikovits, Gerald Timelthaler, F Rényi-Vámos, Clemens Aigner, Konrad Höetzenecker, Viktória László, Karin Schelch, Balázs Döme	2024	2
2	Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms Lung Cancer ·严秀芳, Zsolt Megyesfalvi, Y. Heylen, János Fillinger, E. ROULET, 昭義前原, Orsolya Pipek, К. А. Черепанова, F Rényi-Vámos, Karin Schelch, Christian Lang, Anna Schwendenwein, Kristiina Boettiger, Viktória László, Konrad Höetzenecker, Balázs Döme, Judit Berta	2023	4
3	Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis Thoracic Cancer ·Chimezie Innocent, Karin Schelch, Thomas Mohr, Thomas Klikovits, Christina Wagner, John C. Rees, G. Inama, Katharina Sinn, Báez Mesa Dacmar Andrea, Walter Berger, Bettina Grasl‐Kraupp, Konrad Höetzenecker, Viktória László, Balázs Döme, Balázs Hegedűs, Marko Jakopović, Mir Alireza Hoda, Michael Grusch	2023	1
4	MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction Transplant International ·José Manuel Sanzón-Parra, Alberto Benazzo, Felicitas Oberndorfer, Akinori Iwasaki, Viktória László, Balázs Döme, Mir Ali Reza Hoda, Péter Jaksch, Walter Klepetko, Konrad Höetzenecker	2022	6
5	Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study ESMO Open ·Katharina Sinn, Chimezie Innocent, Ariane Steindl, Marcin Barylski, Karin Dieckmann, Joachim Widder, E.B. Comrie, Walter Klepetko, Konrad Höetzenecker, Viktória László, Ana Cecilia Bacelar Limeira, Thomas Klikovits, Mir Alireza Hoda	2022	7
6	Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer Biology ·Dávid Dóra, Christopher J. Rivard, Hui Yu, Noriaki Yabe, Viktória László, Keila Tomoko Higa Taniguchi, Zsolt Megyesfalvi, Elek Dinya, Lai Shirong, L. Maccarone, Fred R. Hirsch, Balázs Döme, Zoltán Lohinai	2021	27
7	Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo Clinical Cancer Research ·Viktória László, Nakamitsu Yutaka, Ildikó Kovács, Jianjun Luo, Mir Alireza Hoda, Thomas Klikovits, Xiaping Shi, András Czirók, Tamás Garay, هدى أنور عبد العزيز, Thomas H. Helbich, Weimin Teng, József Tóvári, Walter Klepetko, Christine Pirker, Michael Grusch, Walter Berger, Frank Hilberg, Balázs Hegedűs, Balázs Döme	2018	25
8	The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma Journal of Molecular Medicine ·Viktória László, Nakamitsu Yutaka, Jianjun Luo, Ildikó Kovács, Tamás Garay, Mir Alireza Hoda, Thomas Klikovits, Paul Stockhammer, Clemens Aigner, Marion Gröger, Walter Klepetko, Walter Berger, Michael Grusch, József Tóvári, Irene C. Waizenegger, Balázs Döme, Balázs Hegedűs	2018	34
9	Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma Scientific Reports ·Thomas Klikovits, Paul Stockhammer, Viktória László, G. Inama, Mir Alireza Hoda, Bahil Ghanim, Isabelle Opitz, Thomas Frauenfelder, Thi Dan Linh Nguyen‐Kim, Walter Weder, Walter Berger, Michael Grusch, Clemens Aigner, Walter Klepetko, Balázs Döme, F Rényi-Vámos, Rudolf Oehler, Balázs Hegedűs	2017	20
10	Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro Molecular Cancer Therapeutics ·Mir Alireza Hoda, Christine Pirker, G. Inama, Karin Schelch, Petra Heffeter, Kushtrim Kryeziu, Sushilla van Schoonhoven, Thomas Klikovits, Viktória László, Anita Rózsás, Jianjun Luo, Walter Klepetko, Balázs Döme, Michael Grusch, Balázs Hegedűs, Walter Berger	2016	17
11	Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations Pathology & Oncology Research ·Tamás Garay, Eszter Molnár, Éva Juhász, Viktória László, Tamás Barbai, Judit Dobos, Karin Schelch, Christine Pirker, Michael Grusch, Walter Berger, József Tı́már, Balázs Hegedűs	2015	9
12	Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma Journal of Thoracic Oncology ·Zoltán Lohinai, Mir Alireza Hoda, Katalin Fábián, Gyula Ostoros, Erzsébet Rásó, Tamás Barbai, József Tı́már, Ilona Kovalszky, Mihály Cserepes, Anita Rózsás, Viktória László, Michael Grusch, Walter Berger, Walter Klepetko, Judit Moldvay, Balázs Döme, Balázs Hegedűs	2015	62
13	Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy European Journal of Cancer ·Mihály Cserepes, Gyula Ostoros, Zoltán Lohinai, Erzsébet Rásó, Tamás Barbai, József Tı́már, Anita Rózsás, Judit Moldvay, Ilona Kovalszky, Katalin Fábián, Layla Al-Mitib, Bahil Ghanim, Viktória László, Thomas Klikovits, Mir Alireza Hoda, Michael Grusch, Walter Berger, Walter Klepetko, Balázs Hegedűs, Balázs Döme	2014	63
14	Circulating Angiostatin, bFGF, and Tie2/TEK Levels and Their Prognostic Impact in Bladder Cancer Urology ·Tibor Szarvas, Djenaro Barchelot Plata, Viktória László, Gero Kramer, H. Christoph Klingler, F. vom Dorp, Imre Romics, Süleyman Ergün, H. Rübben	2012	10
15	Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: A multi-institutional case–control study Clinica Chimica Acta ·Matthias Zimmermann, Stefanie Nickl, Christopher Lambers, Stefan Hacker, Andreas Mitterbauer, Konrad Höetzenecker, Anita Rózsás, Gyula Ostoros, Viktória László, І. О. Герценок, F Rényi-Vámos, Walter Klepetko, Balázs Döme, Hendrik Jan Ankersmit	2012	47
16	Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer International Journal of Cancer ·Tibor Szarvas, Viktória László, F. vom Dorp, Henning Reis, Attila Szendrői, Imre Romics, Derya Tilki, H. Rübben, Süleyman Ergün	2011	39
17	Lack of Angiogenesis in Experimental Brain Metastases Journal of Neuropathology & Experimental Neurology ·Edina Bugyik, Katalin Dezső, Lilla Reiniger, Viktória László, József Tóvári, József Tı́már, Péter Nagy, Walter Klepetko, Balázs Döme, Sándor Paku	2011	35
18	A New Mechanism for Pillar Formation during Tumor-Induced Intussusceptive Angiogenesis: Inverse Sprouting American Journal Of Pathology ·Sándor Paku, Katalin Dezső, Edina Bugyik, József Tóvári, József Tı́már, Péter Nagy, Viktória László, Walter Klepetko, Balázs Döme	2011	50
19	Development of Arterial Blood Supply in Experimental Liver Metastases American Journal Of Pathology ·Katalin Dezső, Edina Bugyik, 和世藤原, Viktória László, Balázs Döme, József Tóvári, József Tı́már, Péter Nagy, Sándor Paku	2009	35
20	Thy-1 Is Expressed in Hepatic Myofibroblasts and Not Oval Cells in Stem Cell-Mediated Liver Regeneration American Journal Of Pathology ·Katalin Dezső, Peter Jelnes, Viktória László, Kornélia Baghy, Csaba Bödör, Sándor Paku, Niels Tygstrup, Hanne Cathrine Bisgaard, Péter Nagy	2007	59

About Viktória László

Viktória László is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Cancer Research and Cell Biology, having authored 70 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (14 papers), Occupational and environmental lung diseases (12 papers), Lung Cancer Treatments and Mutations (12 papers), Neuroendocrine Tumor Research Advances (8 papers), Medical Imaging and Pathology Studies (7 papers), Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Liver physiology and pathology (5 papers). The work is most often cited by research in Oncology (715 citations), Cancer Research (372 citations), Neurology (360 citations), Hepatology (142 citations) and Pulmonary and Respiratory Medicine (581 citations). Viktória László has collaborated with scholars based in Hungary, Austria and United States. Frequent co-authors include Balázs Döme, Balázs Hegedűs, Walter Klepetko, Mir Alireza Hoda, Sándor Paku, Anita Rózsás, Katalin Dezső, Péter Nagy, Walter Berger and József Tı́már. Their work appears in journals such as Scientific Reports, Lung Cancer, Translational Lung Cancer Research, American Journal Of Pathology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact